Articles

Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference

SELLAS Life Sciences Announces Positive Interim Data from Phase 2b NeuVax™ (nelipepimut-S) Clinical Trial in Combination with Herceptin® in HER2 1 /2 Breast Cancer Patients

POSITIF SUR..UPL

A CHETER... DHFL

ACHETER HSIL

Maruti Suzuki en hausse de 13% en mars, Tata Motors affiche un gain de 31%

ALIBABA............BONJOUR

Joyeuses Pâques

Evogene Files Annual Report for the Year Ended December 31, 2017

The Jean Coutu Group – Dividend Fourth Quarter of Fiscal Year 2018

TiGenix: Transparantiekennisgevingen overeenkomstig Artikel 14 van de wet van 2 mei 2007